Rehab Ecstasy

Addiction Treatment

Search for:

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
Xylazine appears to worsen the life-threatening effects of opioids in rats
Men died of overdose at 2-3 times greater a rate than women in the U.S. in 2020-2021
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
NIH and FDA leaders call for more research, lower barriers to improve and implement drug- checking tools amid overdose epidemic
Young men at highest risk of schizophrenia linked with cannabis use disorder
Anti-poverty programs may help reduce disparities in brain development and mental health symptoms in children
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens

Ribosome by GalussoThemes.com
Powered by WordPress